On the public citation graph
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study
0 signed · 163 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.284.8.1008openalex-snapshot
Preoperative Radiotherapy for Resectable Rectal Cancer
inferredcites →https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<671::aid-cncr3>3.0.co;2-hopenalex-snapshot
Sphincter preservation therapy for distal rectal carcinoma
inferredcites →https://doi.org/10.1002/1097-0142(20010815)92:4<896::aid-cncr1398>3.0.co;2-ropenalex-snapshot
The Stockholm II trial on preoperative radiotherapy in rectal carcinoma
inferredcites →https://doi.org/10.1007/s002800050043openalex-snapshot
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
inferredcites →https://doi.org/10.1007/s003840050072openalex-snapshot
Pathological features of rectal cancer after preoperative radiochemotherapy
inferredcites →https://doi.org/10.1007/s10350-004-6359-xopenalex-snapshot
Quantification of Histologic Regression of Rectal Cancer After Irradiation
inferredcites →https://doi.org/10.1007/s10350-004-6424-5openalex-snapshot
Efficacy of Preoperative Radiation Therapy for Resectable Rectal Adenocarcinoma When Combined With Oral Tegafur-Uracil Modulated With Leucovorin
inferredcites →https://doi.org/10.1016/j.ejca.2003.09.032openalex-snapshot
Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance
inferredcites →https://doi.org/10.1016/j.ijrobp.2004.01.051openalex-snapshot
Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies
inferredcites →https://doi.org/10.1016/s0140-6736(01)06409-1openalex-snapshot
Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials
inferredcites →https://doi.org/10.1016/s0140-6736(86)92612-7openalex-snapshot
LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION
inferredcites →https://doi.org/10.1016/s0167-8140(96)01861-0openalex-snapshot
Age is not a limiting factor for radical radiotherapy in pelvic malignancies
inferredcites →https://doi.org/10.1016/s0360-3016(02)02933-4openalex-snapshot
Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3–T4 unresectable rectal cancer: a phase II IATTGI study
inferredcites →https://doi.org/10.1016/s0360-3016(02)03224-8openalex-snapshot
Preoperative concurrent chemoradiation in locally advanced rectal cancer with 50 Gy and oxaliplatin (OXA), fluorouracil (FU), I-folinic acid (l-LV). The lyon R0-04 phase II trial
inferredcites →https://doi.org/10.1016/s1278-3218(02)00176-2openalex-snapshot
Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials
inferredcites →https://doi.org/10.1056/nejm199103143241101openalex-snapshot
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
inferredcites →https://doi.org/10.1056/nejm199408253310803openalex-snapshot
Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery
inferredcites →https://doi.org/10.1056/nejm199704033361402openalex-snapshot
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
inferredcites →https://doi.org/10.1056/nejmoa010580openalex-snapshot
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
inferredcites →https://doi.org/10.1056/nejmoa032709openalex-snapshot
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
inferredcites →https://doi.org/10.1056/nejmoa040694openalex-snapshot
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
inferredcites →https://doi.org/10.1093/jnci/80.1.21openalex-snapshot
Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011
inferredcites →https://doi.org/10.1097/00000421-200104000-00001openalex-snapshot
Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal Cancer
inferredcites →https://doi.org/10.1097/00000658-199904000-00007openalex-snapshot
Improved Survival and Reduction in Local Failure Rates After Preoperative Radiotherapy
inferredcites →https://doi.org/10.1097/00000658-200207000-00012openalex-snapshot
Long-Term Prognostic Significance of Extent of Rectal Cancer Response to Preoperative Radiation and Chemotherapy
inferredcites →https://doi.org/10.1200/jco.1992.10.4.549openalex-snapshot
Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group.
inferredcites →https://doi.org/10.1200/jco.2000.18.1.136openalex-snapshot
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1200/jco.2000.18.16.2938openalex-snapshot
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
inferredcites →https://doi.org/10.1200/jco.2001.19.9.2433openalex-snapshot
Addition of Oxaliplatin to Continuous Fluorouracil, l -Folinic Acid, and Concomitant Radiotherapy in Rectal Cancer: The Lyon R 97-03 Phase I Trial
inferredcites →https://doi.org/10.1200/jco.2002.02.049openalex-snapshot
Phase I Trial Evaluating the Concurrent Combination of Radiotherapy and Capecitabine in Rectal Cancer
inferredcites →https://doi.org/10.1200/jco.2003.02.505openalex-snapshot
Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer
inferredcites →https://doi.org/10.1200/jco.2003.10.045openalex-snapshot
Preoperative Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer With High-Dose Radiation and Oxaliplatin-Containing Regimen: The Lyon R0–04 Phase II Trial
inferredcites →https://doi.org/10.1200/jco.2004.11.069openalex-snapshot
XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1200/jco.2004.22.14_suppl.3504openalex-snapshot
Does the addition of chemotherapy (CT) to preoperative radiotherapy (preopRT) increase the pathological response in patients with resected rectal cancer : Report of the 22921 EORTC phase III trial
inferredcites →https://doi.org/10.1200/jco.2004.22.14_suppl.3505openalex-snapshot
Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum
inferredcites →https://doi.org/10.1200/jco.2004.22.14_suppl.3575openalex-snapshot
Preliminary phase II SOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC)
inferredcites →https://doi.org/10.1200/jco.2004.22.14_suppl.3607openalex-snapshot
Preoperative chemoradiation with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma
inferredcites →https://doi.org/10.1200/jco.2005.04.171openalex-snapshot
Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer
inferredcites →https://doi.org/10.1200/jco.2005.23.16_suppl.3504openalex-snapshot
Preoperative (preop) radiotherapy (RT) ± 5 FU/folinic acid (FA) in T3–4 rectal cancers: results of the FFCD 9203 randomized trial
inferredcites →https://doi.org/10.1200/jco.2005.23.16_suppl.3576openalex-snapshot
Preoperative radiation and irinotecan in combination with 5 fluorouracil (5-FU) and low-dose leucovorin (LV) in locally advanced rectal cancer (LARC)
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3941038openalex-extracted
Total Neoadjuvant Therapy or Standard Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1002/14651858.cd008531openalex-snapshot
Combination chemotherapy versus single agent chemotherapy during preoperative chemoradiation for resectable rectal cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd008531.pub2openalex-snapshot
Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancer
inferred← citeshttps://doi.org/10.1002/9781118337929.ch12openalex-snapshot
More Treatment is not Necessarily Better – Limited Options for Chemotherapeutic Radiosensitization
inferred← citeshttps://doi.org/10.1002/cncr.25155openalex-snapshot
The role of targeted agents in preoperative chemoradiation for rectal cancer
inferred← citeshttps://doi.org/10.1002/cnr2.1188openalex-snapshot
Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score‐matched analysis
inferred← citeshttps://doi.org/10.1002/jso.21711openalex-snapshot
The impact of preoperative chemoradiotherapy on advanced low rectal cancer
inferred← citeshttps://doi.org/10.1002/jso.23394openalex-snapshot
Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5‐fluorouracil for locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1007/978-1-4020-9545-0_22openalex-snapshot
Chemoradiation for Rectal Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4020-9545-0_25openalex-snapshot
Locally Advanced Rectal Cancer: Combined Chemotherapy During Preoperative Radiation Therapy
inferred← citeshttps://doi.org/10.1007/978-1-60327-459-3_33openalex-snapshot
Pre-operative Radio-Chemotherapy of Rectal Cancer: Toxicity and Preliminary Results with the Addition of Weekly Oxaliplatin
inferred← citeshttps://doi.org/10.1007/s00066-007-9000-9openalex-snapshot
Integration of Novel Agents into Combined-Modality Treatment for Rectal Cancer Patients
inferred← citeshttps://doi.org/10.1007/s00066-010-2182-6openalex-snapshot
Preoperative Oxaliplatin, Capecitabine, and External Beam Radiotherapy in Patients with Newly Diagnosed, Primary Operable, cT3NxM0, Low Rectal Cancer
inferred← citeshttps://doi.org/10.1007/s00066-012-0073-8openalex-snapshot
Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1007/s00066-014-0650-0openalex-snapshot
Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation
inferred← citeshttps://doi.org/10.1007/s00262-011-0988-4openalex-snapshot
Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer
inferred← citeshttps://doi.org/10.1007/s00384-006-0204-8openalex-snapshot
Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: a review
inferred← citeshttps://doi.org/10.1007/s00384-010-1064-9openalex-snapshot
Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution
inferred← citeshttps://doi.org/10.1007/s00761-009-1647-7openalex-snapshot
Neoadjuvantes Behandlungskonzept
inferred← citeshttps://doi.org/10.1007/s10637-008-9192-6openalex-snapshot
Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients
inferred← citeshttps://doi.org/10.1007/s11888-012-0120-yopenalex-snapshot
Potential Novel Drugs to Combine with Radiation in Rectal Cancer
inferred← citeshttps://doi.org/10.1007/s11912-006-0016-6openalex-snapshot
Preoperative and adjuvant treatment of localized rectal cancer
inferred← citeshttps://doi.org/10.1007/s12029-012-9364-7openalex-snapshot
Phase II Trial of Concomitant Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine and Intensity-Modulated Radiotherapy (IMRT) in Rectal Cancer
inferred← citeshttps://doi.org/10.1007/s12032-013-0581-0openalex-snapshot
Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)
inferred← citeshttps://doi.org/10.1007/s12094-012-0826-yopenalex-snapshot
Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience
inferred← citeshttps://doi.org/10.1007/s12094-012-0846-7openalex-snapshot
Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II–III rectal cancer
inferred← citeshttps://doi.org/10.1016/j.canlet.2011.06.026openalex-snapshot
A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer
inferred← citeshttps://doi.org/10.1016/j.carbpol.2021.118237openalex-snapshot
Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer
inferred← citeshttps://doi.org/10.1016/j.clcc.2011.06.007openalex-snapshot
Progress in the Treatment of Locally Advanced Clinically Resectable Rectal Cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2007.07.013openalex-snapshot
Whither Papillon? — Future Directions for Contact Radiotherapy in Rectal Cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2008.02.011openalex-snapshot
Capecitabine, Irinotecan, Oxaliplatin (CAPIRINOX) and Concomitant Irradiation in Advanced Rectal Cancer: The Lyon R-02-01 Phase I Trial
inferred← citeshttps://doi.org/10.1016/j.clon.2009.05.004openalex-snapshot
Chemoradiotherapy in Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2011.12.007openalex-snapshot
Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: What have we learned from a decade of translational research?
inferred← citeshttps://doi.org/10.1016/j.ejca.2008.11.017openalex-snapshot
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study
inferred← citeshttps://doi.org/10.1016/j.ejso.2009.10.002openalex-snapshot
Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum – Toxicity and complications of the treatment
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2006.03.003openalex-snapshot
A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2007.10.023openalex-snapshot
Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.01.020openalex-snapshot
Phase II Study of Weekly Intravenous Oxaliplatin Combined With Oral Daily Capecitabine and Radiotherapy With Biologic Correlates in Neoadjuvant Treatment of Rectal Adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.01.057openalex-snapshot
Phase I Study of Oxaliplatin in Combination With Capecitabine and Radiotherapy as Postoperative Treatment for Stage II and III Rectal Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.04.065openalex-snapshot
Neoadjuvant Treatment With Single-Agent Cetuximab Followed by 5-FU, Cetuximab, and Pelvic Radiotherapy: A Phase II Study in Locally Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.05.054openalex-snapshot
Phase I Study of Preoperative Radiation Therapy With Concurrent Infusional 5-Fluorouracil and Oxaliplatin Followed by Surgery and Postoperative 5-Fluorouracil Plus Leucovorin for T3/T4 Rectal Adenocarcinoma: ECOG E1297
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.11.037openalex-snapshot
Phase I Study of Preoperative Chemoradiation With S-1 and Oxaliplatin in Patients With Locally Advanced Resectable Rectal Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.12.007openalex-snapshot
Oxaliplatin Plus Dual Inhibition of Thymidilate Synthase During Preoperative Pelvic Radiotherapy for Locally Advanced Rectal Carcinoma: Long-Term Outcome
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.12.073openalex-snapshot
Preoperative Chemoradiation With Irinotecan and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: Long-Term Results of a Phase II Study
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2010.05.028openalex-snapshot
Patterns of Response After Preoperative Intensity-Modulated Radiation Therapy and Capecitabine/Oxaliplatin in Rectal Cancer: Is There Still a Place for Ecoendoscopic Ultrasound?
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.05.063openalex-snapshot
Acute Toxicity of Radiochemotherapy in Rectal Cancer Patients: A Risk Particularly for Carriers of the TGFB1 Pro25 variant
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.05.068openalex-snapshot
Phase II Study of Preoperative Helical Tomotherapy With a Simultaneous Integrated Boost for Rectal Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.06.2008openalex-snapshot
Four-Week Neoadjuvant Intensity-Modulated Radiation Therapy With Concurrent Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer Patients: A Validation Phase II Trial
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2017.09.042openalex-snapshot
Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review
inferred← citeshttps://doi.org/10.1016/j.radonc.2007.10.012openalex-snapshot
Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
inferred← citeshttps://doi.org/10.1016/j.radonc.2010.04.004openalex-snapshot
Multicentre phase I–II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study
inferred← citeshttps://doi.org/10.1016/j.radonc.2011.10.018openalex-snapshot
Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: A planning study with clinical implications
inferred← citeshttps://doi.org/10.1016/j.radonc.2013.05.009openalex-snapshot
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: Long-term results of the German CAO/ARO/AIO-94 phase III trial
inferred← citeshttps://doi.org/10.1016/j.semradonc.2011.02.006openalex-snapshot
Beyond 5-Fluorouracil: The Emerging Role of Newer Chemotherapeutics and Targeted Agents with Radiation Therapy
inferred← citeshttps://doi.org/10.1016/j.soc.2010.06.001openalex-snapshot
Chemoradiation for Rectal Cancer: Rationale, Approaches, and Controversies
inferred← citeshttps://doi.org/10.1016/s0305-7372(10)70020-7openalex-snapshot
Update on capecitabine alone and in combination regimens in colorectal cancer patients
inferred← citeshttps://doi.org/10.1038/sj.bjc.6603053openalex-snapshot
Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study
inferred← citeshttps://doi.org/10.1038/sj.bjc.6603645openalex-snapshot
A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1038/sj.bjc.6604292openalex-snapshot
Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study
inferred← citeshttps://doi.org/10.1038/sj.bjc.6604297openalex-snapshot
Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1038/sj.bjc.6604659openalex-snapshot
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial
inferred← citeshttps://doi.org/10.1053/j.scrs.2008.09.003openalex-snapshot
Neoadjuvant Chemoradiation for Rectal Cancer
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2011.05.008openalex-snapshot
Unique Considerations in the Patient With Rectal Cancer
inferred← citeshttps://doi.org/10.1055/s-2007-984861openalex-snapshot
Adjuvant Therapy for Rectal Cancer
inferred← citeshttps://doi.org/10.1080/02841860701317873openalex-snapshot
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1093/annonc/mdj118openalex-snapshot
Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?
inferred← citeshttps://doi.org/10.1093/annonc/mdj119openalex-snapshot
Reply to Letter to the Editor ‘Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?’, by M. G. Fakih (Ann Oncol 2006; 17: 1029)
inferred← citeshttps://doi.org/10.1093/annonc/mdj124openalex-snapshot
Reply to Letter to the Editor ‘Weekly oxaliplatin and pre-operative radiotherapy as a new neoadjuvant therapy for locally advanced rectal cancer’, by T. Watanabe et al. (Ann Oncol 2006; 17: 1173)
inferred← citeshttps://doi.org/10.1093/annonc/mdl085openalex-snapshot
Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation
inferred← citeshttps://doi.org/10.1093/annonc/mdl250openalex-snapshot
A multimodality approach to localized rectal cancer
inferred← citeshttps://doi.org/10.1093/annonc/mdl460openalex-snapshot
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
inferred← citeshttps://doi.org/10.1093/annonc/mdn719openalex-snapshot
Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study
inferred← citeshttps://doi.org/10.1097/cad.0b013e3282f945aaopenalex-snapshot
Capecitabine: an overview of the side effects and their management
inferred← citeshttps://doi.org/10.1097/coc.0b013e3180ca7c9eopenalex-snapshot
Capecitabine and Radiotherapy as Neoadjuvant Treatment for Rectal Cancer
inferred← citeshttps://doi.org/10.1097/coc.0b013e318161dbd3openalex-snapshot
Preoperative Capecitabine and Accelerated Intensity-Modulated Radiotherapy in Locally Advanced Rectal Cancer: A Phase II Trial
inferred← citeshttps://doi.org/10.1097/ppo.0b013e3181e0761copenalex-snapshot
Combined Modality Therapy for Rectal Cancer
inferred← citeshttps://doi.org/10.1111/j.1463-1318.2010.02320.xopenalex-snapshot
Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1155/2012/406568openalex-snapshot
Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-07-1158openalex-snapshot
Radiation Therapy in Stage II and III Rectal Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-07-4025openalex-snapshot
Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement
inferred← citeshttps://doi.org/10.1159/000127383openalex-snapshot
Preoperative Treatment Combining Capecitabine with Radiation Therapy in Rectal Cancer: A GERCOR Phase II Study
inferred← citeshttps://doi.org/10.1177/030089161009600102openalex-snapshot
Comparison between Intensified Neoadjuvant Treatment and Standard Preoperative Chemoradiation for Rectal Cancer
inferred← citeshttps://doi.org/10.1177/030089161410000206openalex-snapshot
Pilot Study of Intense Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Retrospective Review of a Phase II Study
inferred← citeshttps://doi.org/10.1177/147323001003800227openalex-snapshot
Phase II Study of Pre-Operative Radiotherapy with Capecitabine and Oxaliplatin for Rectal Cancer and Carcinoembryonic Antigen as a Predictor of Pathological Tumour Response
inferred← citeshttps://doi.org/10.1186/1477-7819-4-83openalex-snapshot
Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer
inferred← citeshttps://doi.org/10.1186/1748-717x-4-61openalex-snapshot
The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay
inferred← citeshttps://doi.org/10.1186/1756-8722-3-11openalex-snapshot
Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology
inferred← citeshttps://doi.org/10.1186/s13643-018-0678-9openalex-snapshot
Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064)
inferred← citeshttps://doi.org/10.1200/jco.2005.05.0963openalex-snapshot
What Is the Best Way to Predict Disease-Free Survival After Preoperative Radiochemotherapy for Rectal Cancer Patients: Tumor Regression Grading, Nodal Status, or Circumferential Resection Margin Invasion?
inferred← citeshttps://doi.org/10.1200/jco.2006.08.3675openalex-snapshot
Multicenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal Cancer
inferred← citeshttps://doi.org/10.1200/jco.2009.25.8541openalex-snapshot
Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging–Defined, Locally Advanced Rectal Cancer: Grupo Cáncer…
inferred← citeshttps://doi.org/10.1245/s10434-007-9396-6openalex-snapshot
Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
inferred← citeshttps://doi.org/10.1586/14737140.8.2.161openalex-snapshot
Capecitabine plus oxaliplatin for the treatment of colorectal cancer
inferred← citeshttps://doi.org/10.1593/neo.07154openalex-snapshot
Early Changes in Apparent Diffusion Coefficient Predict the Quantitative Antitumoral Activity of Capecitabine, Oxaliplatin, and Irradiation in HT29 Xenografts in Athymic Nude Mice
inferred← citeshttps://doi.org/10.1634/theoncologist.2010-0414openalex-snapshot
Gender-Specific Acute Organ Toxicity during Intensified Preoperative Radiochemotherapy for Rectal Cancer
inferred← citeshttps://doi.org/10.18632/oncotarget.9995openalex-snapshot
Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis
inferred← citeshttps://doi.org/10.2147/cmar.s11250openalex-snapshot
Capecitabine in the management of colorectal cancer
inferred← citeshttps://doi.org/10.2147/ott.s3469openalex-snapshot
Targeting cancers in the gastrointestinal tract: role of capecitabine
inferred← citeshttps://doi.org/10.2165/11633870-000000000-00000openalex-snapshot
The Role of Capecitabine in Locally Advanced Rectal Cancer Treatment
inferred← citeshttps://doi.org/10.21857/yvjrdcn3zyopenalex-snapshot
Neoadjuvant radiotherapy and chemotherapy in localy advanced rectal cancer
inferred← citeshttps://doi.org/10.21873/anticanres.15445openalex-snapshot
Phase II Study of Preoperative Chemoradiotherapy With S-1 Plus Oxaliplatin for Locally Advanced Rectal Cancer (PerSeUS-RC01)
inferred← citeshttps://doi.org/10.2217/crc.15.3openalex-snapshot
How can we determine the best neoadjuvant chemoradiotherapy regimen for rectal cancer?
inferred← citeshttps://doi.org/10.2217/fon.11.7openalex-snapshot
Chemoradiation Therapy in the Management of Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.3109/02841860903536010openalex-snapshot
Cetuximab and chemoradiation for rectal cancer–is the water getting muddy?
inferred← citeshttps://doi.org/10.3389/fsurg.2022.911538openalex-snapshot
Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.3390/molecules13081897openalex-snapshot
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
inferred← citeshttps://doi.org/10.3748/wjg.v13.i44.5805openalex-snapshot
Rectal cancer treatment: Improving the picture
inferred← citeshttps://doi.org/10.3748/wjg.v19.i20.3052openalex-snapshot
Neoadjuvant-intensified treatment for rectal cancer: Time to change?
inferred← citeshttps://doi.org/10.3816/ccc.2007.n.030openalex-snapshot
Combined-Modality Therapy for Rectal Cancer: Future Prospects
inferred← citeshttps://doi.org/10.3816/ccc.2008.n.013openalex-snapshot
The Use of Capecitabine in the Combined-Modality Therapy for Rectal Cancer
inferred← citeshttps://doi.org/10.3816/ccc.2008.n.043openalex-snapshot
Early Clinical Results from Chemoradiation with 5-Fluorouracil and Oxaliplatin for Locally Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.3816/sct.2007.n.017openalex-snapshot
Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine and Intratumor Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase: Is There a Pharmacologic Explanation?
inferred← citeshttps://doi.org/10.4103/bmfj.bmfj_170_17openalex-snapshot
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in locally advanced rectal carcinoma
inferred← citeshttps://doi.org/10.4137/cmro.s1599openalex-snapshot
Colorectal Cancer: Focus on Capecitabine
inferred← citeshttps://doi.org/10.4236/jct.2018.910063openalex-snapshot
Capecitabine and Oxaliplatin versus 5-Fluorouracil in the Neoadjuvant Chemoradiation for Patients with Locally Advanced Rectal Carcinoma: A Comparative Study
inferred← citeshttps://doi.org/10.4251/wjgo.v2.i8.311openalex-snapshot
Capecitabine for locally advanced and metastatic colorectal cancer: A review
inferred← citeshttps://doi.org/10.53846/goediss-4536openalex-snapshot
Die Bedeutung der Thymidinphosphorylase bei Patienten mit lokal fortgeschrittenem Rektumkarzinom (UICC-Stadium-II/-III) im Kontext einer 5-FU basierten multimodalen Therapie
inferred← citeshttps://doi.org/10.53846/goediss-7293openalex-snapshot
Molekular-genetische Prädiktoren der Toxizität einer neo-adjuvanten Radiochemotherapie am Beispiel des Rektumkarzinoms
inferred← citeshttps://doi.org/10.5772/24880openalex-snapshot
Developments in Neoadjuvant Chemotherapy and Radiotherapy in Rectal Cancer
inferred← citeshttps://doi.org/10.6004/jnccn.2013.0041openalex-snapshot
Optimizing Neoadjuvant Therapy for Rectal Cancer With Oxaliplatin
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.